Summary & Overview
HCPCS J1811: Insulin (Fiasp) for Insulin Pump, per 50 Units
HCPCS Level II code J1811 designates insulin (Fiasp) supplied for administration through durable medical equipment (insulin pump) measured per 50 units. This code matters nationally because insulin pump therapy is a common treatment modality for patients with insulin-dependent diabetes, and accurate coding affects access to necessary supplies as well as payer coverage determinations. Key national payers include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.
Readers will find a concise overview of the clinical use of pump-administered rapid-acting insulin, the service context (DME/supply provisioning), and the billing implications tied to this HCPCS Level II code. The publication summarizes coverage landscape elements and payer-specific considerations, outlines typical sites of service for billing, and highlights where data is not available in the input. Content also addresses commonly associated modifiers and ancillary fields where provided. This piece is intended to inform billing staff, revenue cycle professionals, and policy analysts about the role of J1811 in claims submission and supply provisioning for insulin pump therapy on a national level.
Billing Code Overview
HCPCS Level II code J1811 represents insulin (fiasp) for administration through DME (i.e., insulin pump) per 50 units. This code is used to bill for insulin supplied specifically for use in durable medical equipment insulin pumps.
-
Service type: Prescription medication supplied for pump infusion
-
Typical site of service: Durable medical equipment use, typically billed in settings where patients receive supplies for insulin pump therapy such as outpatient clinics, specialty pharmacies, home infusion, or DME suppliers
Clinical & Coding Specifications
Clinical Context
A 28-year-old adult with type 1 diabetes managed with an insulin pump presents for routine supply provision and pump reservoir refill. The patient uses rapid-acting insulin Fiasp delivered via a durable medical equipment (DME) insulin pump and requires a 50-unit vial/cartridge replacement for ongoing continuous subcutaneous insulin infusion. The clinical workflow begins with the patient contacting their DME supplier or diabetes clinic for a prescription or refill order. The prescriber documents the indication (e.g., unstable glucose control or routine maintenance), writes a prescription specifying J1811 (insulin [fiasp] for administration through DME per 50 units), and includes pump therapy details. The DME supplier verifies insurance eligibility, applies appropriate modifiers for billing when needed, dispenses the insulin cartridge or vial, and documents lot numbers and patient education on pump reservoir filling and infusion set changes. Follow-up includes remote or in-person blood glucose review and routine pump supply orders every 30–90 days depending on usage and payer rules.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
JW | Drug amount discarded/not administered | When part of the dispensed insulin is discarded (e.g., partial vial/cartridge wasted) and documentation supports waste. |